Genomictree (228760.KQ) Stock Price
Genomictree Price
Revenue has compounded at 13.6% per year over the past 10 years to 3.76 B KRW. Genomictree's net margin stands at -239.0%, down from -222.3% several years earlier.
Genomictree stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Genomictree business model & stock analysis
Frequently asked questions about Genomictree
5 analysts currently rate the Genomictree stock: 4 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Genomictree to generate revenue of 7.80 B KRW and earnings per share of -141.17 KRW.
Converted at the current exchange rate, the Genomictree share trades at 6.43 EUR (9,600.00 KRW).
The expected revenue of Genomictree is 7.80 B KRW. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Genomictree is -3.46 B KRW. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Genomictree is currently -68.00. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Genomictree stock.
The price-to-sales ratio (P/S) of Genomictree is currently 30.19. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Genomictree stock.
The Eulerpool Quality Score for Genomictree is 2/10.
The ISIN of Genomictree is KR7228760005. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Genomictree is 228760.KQ. The ticker symbol is used to trade Genomictree shares on the stock exchange.
Genomictree stock
Genomictree Peer Group
Genomictree FIGI
All fundamentals and in-depth analysis of Genomictree
Our stock analysis for Genomictree stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Genomictree. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.